Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Lonaprisan

From Wikipedia, the free encyclopedia
Chemical compound
Pharmaceutical compound
Lonaprisan
Clinical data
Other namesZK-230211; BAY 86-5044; ZK-PRA; 11β-(4-acetylphenyl)-17β-hydroxy-17α-(1,1,2,2,2-pentafluoroethyl)estra-4,9-dien-3-one
Routes of
administration
Oral
Identifiers
  • (8S,11R,13S,14S,17S)-11-(4-acetylphenyl)-17-hydroxy-13-methyl-17-(1,1,2,2,2-pentafluoroethyl)-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one
CAS Number
PubChemCID
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard(EPA)
ECHA InfoCard100.190.674Edit this at Wikidata
Chemical and physical data
FormulaC28H29F5O3
Molar mass508.529 g·mol−1
3D model (JSmol)
  • CC(=O)C1=CC=C(C=C1)[C@H]2C[C@]3([C@@H](CC[C@]3(C(C(F)(F)F)(F)F)O)[C@H]4C2=C5CCC(=O)C=C5CC4)C
  • InChI=1S/C28H29F5O3/c1-15(34)16-3-5-17(6-4-16)22-14-25(2)23(11-12-26(25,36)27(29,30)28(31,32)33)21-9-7-18-13-19(35)8-10-20(18)24(21)22/h3-6,13,21-23,36H,7-12,14H2,1-2H3/t21-,22+,23-,25-,26-/m0/s1
  • Key:VHZPUDNSVGRVMB-RXDLHWJPSA-N

Lonaprisan (INN,USAN) (developmental code namesZK-230211,BAY 86-5044,ZK-PRA) is asynthetic,steroidalantiprogestogen which was under development byBayer HealthCare Pharmaceuticals for the treatment ofendometriosis,dysmenorrhea, andbreast cancer but was discontinued.[1][2][3] It is apotent and highlyselectivesilent antagonist of theprogesterone receptor (PR).[2][3][4] The drug reachedphase IIclinical trials prior to its discontinuation.[1]

See also

[edit]

References

[edit]
  1. ^ab"Lonaprisan - AdisInsight".adisinsight.springer.com.
  2. ^abWhitaker LH, Williams AR, Critchley HO (2014). "Selective progesterone receptor modulators".Curr. Opin. Obstet. Gynecol.26 (4):237–42.doi:10.1097/GCO.0000000000000082.PMID 24950125.S2CID 37474964.
  3. ^abPluchino N, Freschi L, Wenger JM, Streuli I (2016). "Innovations in classical hormonal targets for endometriosis".Expert Rev Clin Pharmacol.9 (2):317–27.doi:10.1586/17512433.2016.1129895.PMID 26645363.S2CID 8624056.
  4. ^Busia L, Faus H, Hoffmann J, Haendler B (2011). "The antiprogestin Lonaprisan inhibits breast cancer cell proliferation by inducing p21 expression".Mol. Cell. Endocrinol.333 (1):37–46.doi:10.1016/j.mce.2010.11.034.PMID 21138753.S2CID 12818061.

External links

[edit]
PRTooltip Progesterone receptor
Agonists
Mixed
(SPRMsTooltip Selective progesterone receptor modulators)
Antagonists
mPRTooltip Membrane progesterone receptor
(PAQRTooltip Progestin and adipoQ receptor)
Agonists
Antagonists
Portal:


Stub icon

This article about asteroid is astub. You can help Wikipedia byexpanding it.

Stub icon

Thisdrug article relating to thegenito-urinary system is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Lonaprisan&oldid=1301017310"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp